Physician profile
Stephen E Lemos
NPI 1740232792
$5,356.89
in general payments reported to CMS, 2019-2025
13 companies · $1,082 in 2025
The $1,082 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $889 · 2020: $557 · 2021: $274 · 2022: $1,396 · 2023: $140 · 2024: $1,018 · 2025: $1,082.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,297 · Food and Beverage: $943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,297.43 |
| Food and Beverage | $943.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $2,292.00 | 2019-2022 | |
| Encore Medical, LP | $1,057.41 | 2025 | Djo Surgical |
| Linvatec Corporation | $550.44 | 2024 | Biobrace 23mm, Livatec Knee Preservation System |
| Djo, LLC | $468.11 | 2019-2023 | Cmf |
| Fx Shoulder Solutions, INC | $379.03 | 2024 | |
| Stryker Corporation | $136.77 | 2019 | |
| Depuy Synthes Sales INC. | $126.00 | 2023 | Na |
| Smith+Nephew, INC. | $115.11 | 2021-2024 | Evos, Trigen Intertan |
| Aesculap Biologics, LLC | $108.90 | 2021 | |
| Zimmer Biomet Holdings, INC. | $58.83 | 2022 | |
| Hologic Sales and Service, LLC | $25.08 | 2025 | Fluent Fluid Management System |
| Abbvie INC. | $19.61 | 2021 | |
| Fidia Pharma USA INC. | $19.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Lemos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.